J Korean Diabetes.  2011 Jun;12(2):69-71. 10.4093/jkd.2011.12.2.69.

Diabetic Foot: Past and Present

• Lee JH
• Chung CH

• KMID: 2137323
• DOI: http://doi.org/10.4093/jkd.2011.12.2.69

Abstract

Diabetic foot is one of the most serious complications of diabetes, and is associated with significant portions of admission, medical cost, disability and mortality in diabetic patients. According to a recent report from the Korean Diabetes Association Basic Statistics Research Task Force Team, 1.2% of Korean diabetic patients had diabetic foot, representing a decrease since 1980. The age at amputation increased since 1980, from 60 to 70 years of age, while the mortality rate decreased due to advances of therapeutic technology. Further epidemiologic studies are required to obtain current data regarding incidence, amputation rates, and mortality, and to identify risk factors and new therapeutic modalities in diabetic foot.

Keyword

Diabetic foot; Amputation; Ulcer; Epidemiology

MeSH Terms

Advisory Committees
Amputation
Diabetic Foot
Humans
Incidence
Risk Factors
Ulcer

Reference

1. Diabetic Foot. Korean Diabetes Association. Diabetes Mellitus. Seoul: Korean Diabetes Association;2006. p. 518–26.

2. Boulton AJM. Foot problems in patients with diabetes mellitus. Pickup JC, Williams G, editors. Textbook of diabetes. Vol. 2. Oxford: Blackwell Science;1997. p. 58.

3. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983; 6:87–91.

4. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care. 1993; 16:16–20.

5. Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996; 13:967–72.

6. Rowbotham JL, Gibbons GW, Kozak GP. The diabetic foot. Kozak GP, editor. Kozak's clinical diabetes mellitus. Philadelphia: W.B. Saunders Co.;1982. p. 215–28.

7. Lee MK, Chung MH, Won AO, Kim SY, Lee HK, Min HK. A clinical observation on the diabetic foot lesions. J Korean Diabetes Assoc. 1984; 8:55–65.

8. Kwon YJ, Han KA, Sung SK, Yoo HJ. A clinical study on the diabetic foot lesions. J Korean Diabetes Assoc. 1989; 13:39–45.

9. Chung CH, Kim DJ, Kim J, Kim H, Kim H, Min KW, Park SW, Park JH, Baik SH, Son HS, Ahn CW, Oh JY, Lee S, Lee J, Choi KM, Choi I, Park IB. Current status of diabetic foot in Korean patients using National Health Insurance database. J Korean Diabetes Assoc. 2006; 30:372–6.

10. Boulton AJM, Cavanagh PR, Rayman G. The description and classification of diabetic foot lesions: systems for clinical care, for research and for audit. The description and classification of diabetic foot lesions: systems for clinical care, for research and for audit. Jeffcoate WJ, Game FL, editors. The foot in diabetes. 4th ed.Chichester: John Wiley & Sons, Ltd.;2006. p. 92–107.

11. Altavilla D, Bitto A, Polito F, Marini H, Minutoli L, Di Stefano V, Irrera N, Cattarini G, Squadrito F. Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. Cardiovasc Hematol Agents Med Chem. 2009; 7:313–21.

12. Villela DL, Santos VL. Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors. 2010; 28:111–6.

13. O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T. Review paper: basic concepts to novel therapies: a review of the diabetic foot. Int J Low Extrem Wounds. 2010; 9:90–102.

14. Teng YJ, Li YP, Wang JW, Yang KH, Zhang YC, Wang YJ, Tian JH, Ma B, Wang JM, Yan X. Bioengineered skin in diabetic foot ulcers. Diabetes Obes Metab. 2010; 12:307–15.

15. Kim JH, Jung M, Kim HS, Kim YM, Choi EH. Adipose-derived stem cells as a new therapeutic modality for ageing skin. Exp Dermatol. 2011; 20:383–7.